Article
Hepatocyte-Targeted siTAZ Therapy Lowers Liver Fibrosis in NASH Diet-Fed Chimeric Mice…
medRxiv · 2023 · Wang, X.; Moore, M. P.; Shi, H.; Miyata, Y.; Donnelly, S. K.; Radiloff, D. R.; Tabas, I.
Key facts
| Title | Hepatocyte-Targeted siTAZ Therapy Lowers Liver Fibrosis in NASH Diet-Fed Chimeric Mice with Hepatocyte-Humanized Livers |
|---|---|
| First author | Wang, X.; Moore, M. P.; Shi, H.; Miyata, Y.; Donnelly, S. K.; Radiloff, D. R.; Tabas, I. |
| Journal | medRxiv |
| Published | Nov 1, 2023 |
| DOI | 10.1101/2023.10.27.564478 |
| Devices mentioned | K040782, K103302, K875071, K981650 |
| Product codes mentioned | CIT, JAK, NDS, JJH, NJT, OOI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1